Dec 15, 2020 8:04am EST DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
Dec 10, 2020 8:03am EST DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
Nov 19, 2020 9:04am EST DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 11, 2020 8:30am EST DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference
Nov 04, 2020 4:30pm EST DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results
Oct 28, 2020 8:30am EDT DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020
Sep 15, 2020 8:15am EDT DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
Sep 14, 2020 9:15am EDT DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study
Aug 11, 2020 4:05pm EDT DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results